<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35910083</PMID><DateRevised><Year>2022</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2633-1055</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Neuroscience insights</Title><ISOAbbreviation>Neurosci Insights</ISOAbbreviation></Journal><ArticleTitle>At the Root of 3 "Long" Diseases: Persistent Antigens Inflicting Chronic Damage on the Brain and Other Organs in Gulf War Illness, Long-COVID-19, and Chronic Fatigue Syndrome.</ArticleTitle><Pagination><StartPage>26331055221114817</StartPage><MedlinePgn>26331055221114817</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">26331055221114817</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/26331055221114817</ELocationID><Abstract><AbstractText>Several foreign antigens such as those derived from viruses and bacteria have been linked to long-term deleterious effects on the brain and other organs; yet, health outcomes subsequent to foreign antigen exposure vary depending in large part on the host's immune system, in general, and on human leukocyte antigen (HLA) composition, in particular. Here we first provide a brief description of 3 conditions characterized by persistent long-term symptoms, namely long-COVID-19, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and Gulf War Illness (GWI), followed by a brief overview of the role of HLA in the immune response to foreign antigens. We then discuss our Persistent Antigen (PA) hypothesis and highlight associations between antigen persistence due to HLA-antigen incongruence and chronic health conditions in general and the 3 "long" diseases above in particular. This review is not intended to cover the breadth and depth of symptomatology of those diseases but is specifically focused on the hypothesis that the presence of persistent antigens underlies their pathogenesis.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>James</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Veterans Affairs Health Care System, Brain Sciences Center, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Cognitive Sciences, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Georgopoulos</LastName><ForeName>Apostolos P</ForeName><Initials>AP</Initials><Identifier Source="ORCID">0000-0003-4412-725X</Identifier><AffiliationInfo><Affiliation>Department of Veterans Affairs Health Care System, Brain Sciences Center, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Cognitive Sciences, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurosci Insights</MedlineTA><NlmUniqueID>101760670</NlmUniqueID><ISSNLinking>2633-1055</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gulf War illness</Keyword><Keyword MajorTopicYN="N">Human leukocyte antigen</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">persistent antigen</Keyword></KeywordList><CoiStatement>Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>1</Day><Hour>3</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35910083</ArticleId><ArticleId IdType="pmc">PMC9335483</ArticleId><ArticleId IdType="doi">10.1177/26331055221114817</ArticleId><ArticleId IdType="pii">10.1177_26331055221114817</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>James L, Georgopoulos A. Persistent antigens hypothesis: the human leukocyte antigen (HLA) connection. J Neurol Neuromed. 2018;3:27-31.</Citation></Reference><Reference><Citation>
WHO Coronavirus (COVID-19) Dashboard | Geneva: World Helath Organization, 2020. Accessed March 31, 2022. Available https://covid19.who.int/</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al.. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, et al.. Persistent symptoms in adult patients 1 year after Coronavirus Disease 2019 (COVID-19): a Prospective Cohort Study. Clin Infect Dis. 2022;74:1191-1198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute covid-19. JAMA. 2020;324:603-605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, et al.. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4:e210830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al.. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2014; United States, March&#x2013;June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:993-998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O&#x2019;Brien K, Martin-Loeches I, Nadarajan P, Bannan C. Reply: the relation between persistent poor health after COVID-19 and respiratory complications or initial disease severity. Ann Am Thorac Soc. 2021;18:1431-1432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8513647</ArticleId><ArticleId IdType="pubmed">33596163</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. Published online 25 May 2022. doi:10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Maralakunte M, Garg S, et al.. The conundrum of &#x2018;long-COVID-19&#x2019;: a narrative review. Int J Gen Med. 2021;14:2491-2506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al.. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583-590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathmann W, Kuss O, Kostev K. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia. 2022;65:949-954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8923743</ArticleId><ArticleId IdType="pubmed">35292829</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Ravent&#xf3;s B, Roel E, et al.. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ. 2022;e068373. 10.1136/bmj-2021-068373</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068373</ArticleId><ArticleId IdType="pmc">PMC8924704</ArticleId><ArticleId IdType="pubmed">35296468</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33:155-162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7880581</ArticleId><ArticleId IdType="pubmed">33332890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M, Tincani A, Andreoli L, et al.. Covid-19 and autoimmunity. Autoimmun Rev. 2020;19:102597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, et al..; COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11:e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, et al.. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697-707. Published online Mar 7, 2022. doi:10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi AI, Baskett WI, Huang W, Naqvi SH, Shyu CR. New-onset dementia among survivors of pneumonia associated with severe acute respiratory syndrome coronavirus 2 infection. Open Forum Infect Dis. 2022;9:ofac115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903511</ArticleId><ArticleId IdType="pubmed">35350170</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Deleterious outcomes in long-hauler COVID-19: the effects of SARS-CoV-2 on the CNS in Chronic COVID syndrome. ACS Chem Neurosci. 2020;11:4017-4020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33275404</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: The National Academies Press, 2015. 10.17226/19012.</Citation><ArticleIdList><ArticleId IdType="doi">10.17226/19012</ArticleId><ArticleId IdType="pubmed">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12:698169. 1494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med. 2021;27:895-906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen SA. Gulf war veterans' health: medical evaluation of a US cohort. Ann Intern Med. 2005;142:881-890.</Citation><ArticleIdList><ArticleId IdType="pubmed">15941694</ArticleId></ArticleIdList></Reference><Reference><Citation>Kipen HM, Hallman W, Kang H, Fiedler N, Natelson BH. Prevalence of chronic fatigue and chemical sensitivities in Gulf registry veterans. Arch Environ Health. 1999;54:313-318.</Citation><ArticleIdList><ArticleId IdType="pubmed">10501146</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. 2020;18:100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7038594</ArticleId><ArticleId IdType="pubmed">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Falk Hvidberg M, Brinth LS, Olesen AV, Petersen KD, Ehlers L. The health-related quality of life for patients with myalgic encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS). PLoS One. 2015;10:e0132421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4492975</ArticleId><ArticleId IdType="pubmed">26147503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lande A, Fluge Strand E.B, et al.. Human leukocyte antigen alleles associated with myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Sci Rep. 2020;10:5267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7093502</ArticleId><ArticleId IdType="pubmed">32210306</ArticleId></ArticleIdList></Reference><Reference><Citation>Fappiano CM, Baraniuk JN. Gulf war illness symptom severity and onset: A cross-sectional survey. Mil Med. 2020;185:e1120-e1127.</Citation><ArticleIdList><ArticleId IdType="pubmed">32009157</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang HK, Li B, Mahan CM, Eisen SA, Engel CC. Health of US veterans of 1991 Gulf war: a follow-up survey in 10 years. J Occup Environ Med. 2009;51:401-410.</Citation><ArticleIdList><ArticleId IdType="pubmed">19322107</ArticleId></ArticleIdList></Reference><Reference><Citation>Dursa EK, Barth SK, Porter BW, Schneiderman AI. Health status of female and male Gulf war and Gulf Era Veterans: A population-based study. Womens Health Issues. 2019;29 Suppl 1:S39-S46.</Citation><ArticleIdList><ArticleId IdType="pubmed">31253241</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MC, Sims KJ, Gifford EJ, et al.. Gender-based differences among 1990-1991 Gulf war era veterans: demographics, lifestyle behaviors, and health conditions. Womens Health Issues. 2019;29 Suppl 1:S47-S55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6668031</ArticleId><ArticleId IdType="pubmed">31253242</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Nisenbaum R, Stewart G, et al.. Chronic multisymptom illness affecting Air Force veterans of the Gulf war. JAMA. 1998;280:981-988.</Citation><ArticleIdList><ArticleId IdType="pubmed">9749480</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele L. Prevalence and patterns of Gulf war illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service. Am J Epidemiol. 2000;152:992-1002.</Citation><ArticleIdList><ArticleId IdType="pubmed">11092441</ArticleId></ArticleIdList></Reference><Reference><Citation>White RF, Steele L, O&#x2019;Callaghan JP, et al.. Recent research on Gulf war illness and other health problems in veterans of the 1991 Gulf war: Effects of toxicant exposures during deployment. Cortex. 2016;74:449-475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4724528</ArticleId><ArticleId IdType="pubmed">26493934</ArticleId></ArticleIdList></Reference><Reference><Citation>Engdahl BE, James LM, Miller RD, et al.. A magnetoencephalographic (MEG) study of Gulf War Illness (GWI). EBioMedicine. 2016;12:127-132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5078573</ArticleId><ArticleId IdType="pubmed">27592598</ArticleId></ArticleIdList></Reference><Reference><Citation>Christova P, James LM, Engdahl BE, Lewis SM, Carpenter AF, Georgopoulos AP. Subcortical brain atrophy in Gulf war Illness. Exp Brain Res. 2017;235:2777-2786.</Citation><ArticleIdList><ArticleId IdType="pubmed">28634886</ArticleId></ArticleIdList></Reference><Reference><Citation>Christova P, James L, Carpenter A, et al.. C-reactive protein is associated with brain white matter anomalies in Gulf war Illness. J Neurol Neuromed. 2020;5:55-62.</Citation></Reference><Reference><Citation>Christova P, James L, Carpenter A, et al.. Gulf war Illness: C-reactive protein is associated with reduction of the volume of hippocampus and decreased fractional anisotropy of the fornix. J Neurol Neuromed. 2020;5:6-15.</Citation></Reference><Reference><Citation>Christova P, James L, Carpenter A, Lewis S, Engdahl B, Georgopoulos A. Human leukocyte antigen (HLA) alleles prevent metabolically-induced inflammation and cerebrocortical thinning in Gulf war Illness. J Neurol Neuromed. 2020;5:16-27.</Citation></Reference><Reference><Citation>Institute of Medicine. Chronic Multisymptom Illness in Gulf War Veterans: Case Definitions Reexamined. Washington, DC: The National Academies Press; 2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">25590117</ArticleId></ArticleIdList></Reference><Reference><Citation>Gifford EJ, Vahey J, Hauser ER, et al.. Gulf war illness in the Gulf war era cohort and biorepository: the Kansas and Centers for Disease Control definitions. Life Sci. 2021;278:119454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10148241</ArticleId><ArticleId IdType="pubmed">33811897</ArticleId></ArticleIdList></Reference><Reference><Citation>National Academies of Sciences, Engineering, and Medicine. Gulf War and Health: Volume 10: Update of Health Effects of Serving in the Gulf War, 2016. Washington, DC: The National Academies Press; 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine National Research Council. Gulf War and Health: Volume 1. Depleted Uranium, Pyridostigmine Bromide, Sarin, and Vaccines. National Academies Press; 2000.</Citation><ArticleIdList><ArticleId IdType="pubmed">25057724</ArticleId></ArticleIdList></Reference><Reference><Citation>Takafuji ET, Russell PK. Military immunizations: Past, present, and future prospects. Infect Dis Clin North Am. 1990;4:143-158.</Citation><ArticleIdList><ArticleId IdType="pubmed">2407777</ArticleId></ArticleIdList></Reference><Reference><Citation>OSAGWI (Office of the Special Assistant for Gulf War Illnesses). Military Medical Recordkeeping During and After the Gulf War: Interim Report. U.S. Department of Defense; 1999.</Citation></Reference><Reference><Citation>Georgopoulos AP, James LM, Mahan MY, Joseph J, Georgopoulos A, Engdahl BE. Reduced human leukocyte antigen (HLA) protection in Gulf War Illness (GWI). EBioMedicine. 2016;3:79-85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4739436</ArticleId><ArticleId IdType="pubmed">26870819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotopf M, David A, Hull L, Ismail K, Unwin C, Wessely S. Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study. BMJ. 2000;320:1363-1367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27378</ArticleId><ArticleId IdType="pubmed">10818024</ArticleId></ArticleIdList></Reference><Reference><Citation>Unwin C, Blatchley N, Coker W, et al.. Health of UK servicemen who served in Persian Gulf War. Lancet. 1999;353:169-178.</Citation><ArticleIdList><ArticleId IdType="pubmed">9923871</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilibary EP, Souto E, Kratzke M, James L, Engdahl B, Georgopoulos A. Anthrax and Gulf War Illness (GWI): Evidence for the presence of harmful anthrax antigen PA63 in the serum of veterans with GWI. J Neurol Neuromed. 2019;4:1-9.</Citation></Reference><Reference><Citation>Tsilibary EC, Souto EP, Kratzke M, James LM, Engdahl BE, Georgopoulos AP. Anthrax protective antigen 63 (PA63): Toxic effects in neural cultures and role in Gulf War Illness (GWI). Neurosci Insights. 2020;15:2633105520931966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7328487</ArticleId><ArticleId IdType="pubmed">32656531</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilibary EC, Souto EP, Kratzke M, James LM, Engdahl BE, Georgopoulos AP. Vaccine-induced adverse effects in cultured neuroblastoma 2A (N2A) cells duplicate toxicity of serum from patients with Gulf war Illness (GWI) and are prevented in the presence of specific anti-vaccine antibodies. Vaccines. 2020;8:232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349801</ArticleId><ArticleId IdType="pubmed">32443454</ArticleId></ArticleIdList></Reference><Reference><Citation>Israeli E. Gulf war syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvant (ASIA). Lupus. 2012;21:190-194.</Citation><ArticleIdList><ArticleId IdType="pubmed">22235052</ArticleId></ArticleIdList></Reference><Reference><Citation>Toubi E. ASIA&#x2014;Autoimmune syndromes induced by adjuvants: rare, but worth considering. Israel Med Assoc J. 2012;14:121.</Citation><ArticleIdList><ArticleId IdType="pubmed">22693796</ArticleId></ArticleIdList></Reference><Reference><Citation>Pel&#xe0; G, Goldoni M, Solinas E, et al.. Sex-related differences in long-COVID-19 syndrome. J Womens Health. 2022;31:620-630.</Citation><ArticleIdList><ArticleId IdType="pubmed">35333613</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022:S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, et al.. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28:611.e9-611.e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Faro M, S&#xe0;ez-Franc&#xe1;s N, Castro-Marrero J, Aliste L, Fern&#xe1;ndez de, Sevilla T, Alegre J. Gender differences in chronic fatigue syndrome. Reumatol Clin. 2016;12:72-77.</Citation><ArticleIdList><ArticleId IdType="pubmed">26190206</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller SN, Rouse BT. Immune responses to viruses. Clin Immunol. 2008;421-431.</Citation></Reference><Reference><Citation>Beutler B. Innate immunity: an overview. Mol Immunol. 2004;40:845-859.</Citation><ArticleIdList><ArticleId IdType="pubmed">14698223</ArticleId></ArticleIdList></Reference><Reference><Citation>Klenerman P, Hill A. T cells and viral persistence: lessons from diverse infections. Nat Immunol. 2005;6:873-879.</Citation><ArticleIdList><ArticleId IdType="pubmed">16116467</ArticleId></ArticleIdList></Reference><Reference><Citation>Eligio P, Delia R, Valeria G. EBV chronic infections. Mediterr J Hematol Infect Dis. 2010;2:e2010022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3033110</ArticleId><ArticleId IdType="pubmed">21415952</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouse BT, Kaistha SD. A tale of 2 alpha-herpesviruses: lessons for vaccinologists. Clin Infect Dis. 2006;42:810-817.</Citation><ArticleIdList><ArticleId IdType="pubmed">16477558</ArticleId></ArticleIdList></Reference><Reference><Citation>Meuer SC, Hussey RE, Hodgdon JC, Hercend T, Schlossman SF, Reinherz EL. Surface structures involved in target recognition by human cytotoxic T lymphocytes. Science. 1982;218:471-473.</Citation><ArticleIdList><ArticleId IdType="pubmed">6981845</ArticleId></ArticleIdList></Reference><Reference><Citation>Hov JR, Kosmoliaptsis V, Traherne JA, et al.. Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis. Hepatology. 2011;53:1967-1976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128712</ArticleId><ArticleId IdType="pubmed">21413052</ArticleId></ArticleIdList></Reference><Reference><Citation>Dendrou CA, Petersen J, Rossjohn J, Fugger L. HLA variation and disease. Nat Rev Immunol. 2018;18:325-339.</Citation><ArticleIdList><ArticleId IdType="pubmed">29292391</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggieri A, Anticoli S, D&#x2019;Ambrosio A, Giordani L, Viora M. The influence of sex and gender on immunity, infection and vaccination. Ann Ist Super Sanita. 2016;52:198-204.</Citation><ArticleIdList><ArticleId IdType="pubmed">27364394</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischinger S, Boudreau CM, Butler AL, Streeck H, Alter G. Sex differences in vaccine-induced humoral immunity. Semin Immunopathol. 2019;41:239-249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6373179</ArticleId><ArticleId IdType="pubmed">30547182</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin H, Wherry EJ. CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol. 2007;19:408-415.</Citation><ArticleIdList><ArticleId IdType="pubmed">17656078</ArticleId></ArticleIdList></Reference><Reference><Citation>Hope JL, Stairiker CJ, Bae EA, Otero DC, Bradley LM. Striking a balance-cellular and molecular drivers of memory T cell development and responses to chronic stimulation. Front Immunol. 2019;10:1595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6650570</ArticleId><ArticleId IdType="pubmed">31379821</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo GD, Lazarini F, Levallois S, et al.. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med. 2021;13:eabf8396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow D, Stein S, Ramelli S, et al.. SARS-CoV-2 infection and persistence throughout the human body and brain. Research Square. 2021. Preprint posted online December 20, 2021. 10.21203/rs.3.rs-1139035/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1139035/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, et al.. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639-644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibholm LK, Nielsen SSF, Pahus MH, et al.. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine. 2021;64:103230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7847186</ArticleId><ArticleId IdType="pubmed">33530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrah SA, Kmetiuk LB, de Carvalho OV, et al.. Persistent SARS-CoV-2 antigen presence in multiple organs of a naturally infected cat from Brazil. J Venom Anim Toxins Incl Trop Dis. 2022;28:e20210074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8906534</ArticleId><ArticleId IdType="pubmed">35310131</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew S, Faheem M, Ibrahim SM, et al.. Hepatitis C virus and neurological damage. World J Hepatol. 2016;8:545-556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4840160</ArticleId><ArticleId IdType="pubmed">27134702</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo CY, Tang YG, Qi ZL, et al.. Development and characterization of a panel of cross-reactive monoclonal antibodies generated using H1N1 influenza virus. Immunobiology. 2015;220:941-946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7124281</ArticleId><ArticleId IdType="pubmed">25708705</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkanen TO, Alakuijala APE, Dauvilliers YA, Partinen MM. Incidence of narcolepsy after H1N1 influenza and vaccinations: systematic review and meta-analysis. Sleep Med Rev. 2018;38:177-186.</Citation><ArticleIdList><ArticleId IdType="pubmed">28847694</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis. 2004;189:1411-1418.</Citation><ArticleIdList><ArticleId IdType="pubmed">15073678</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo D, Hoare A, Soto C, Valenzuela MA, Quest AF. Helicobacter pyloriin human health and disease: mechanisms for local gastric and systemic effects. World J Gastroenterol. 2018;24:3071-3089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6064966</ArticleId><ArticleId IdType="pubmed">30065554</ArticleId></ArticleIdList></Reference><Reference><Citation>Getts DR, Chastain EM, Terry RL, Miller SD. Virus infection, antiviral immunity, and autoimmunity. Immunol Rev. 2013;255:197-209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3971377</ArticleId><ArticleId IdType="pubmed">23947356</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson Pa, 2nd, McGavern DB. Viral diseases of the central nervous system. Curr Opin Virol. 2015;11:44-54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4456224</ArticleId><ArticleId IdType="pubmed">25681709</ArticleId></ArticleIdList></Reference><Reference><Citation>Haruwaka K, Ikegami A, Tachibana Y, et al.. Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun. 2019;10:5816-5817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6925219</ArticleId><ArticleId IdType="pubmed">31862977</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher NF, McKeating JA. Hepatitis C virus and the brain. J Viral Hepat. 2012;19:301-306.</Citation><ArticleIdList><ArticleId IdType="pubmed">22497808</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenig S, Gendelman HE, Orenstein JM, et al.. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 1986;233:1089-1093.</Citation><ArticleIdList><ArticleId IdType="pubmed">3016903</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcocci ME, Napoletani G, Protto V, et al.. Herpes simplex virus-1 in the brain: the dark side of a sneaky infection. Trends Microbiol. 2020;28:808-820.</Citation><ArticleIdList><ArticleId IdType="pubmed">32386801</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesoriero C, Codita A, Zhang MD, et al.. H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice. PNAS. 2016;113:E368-E377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4725525</ArticleId><ArticleId IdType="pubmed">26668381</ArticleId></ArticleIdList></Reference><Reference><Citation>Martines RB, Bhatnagar J, de Oliveira Ramos AM, et al.. Pathology of congenital Zika syndrome in Brazil: a case series. Lancet. 2016;388:898-904.</Citation><ArticleIdList><ArticleId IdType="pubmed">27372395</ArticleId></ArticleIdList></Reference><Reference><Citation>Houen G, Trier NH. Epstein-barr virus and systemic autoimmune diseases. Front Immunol. 2021;11:587380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7817975</ArticleId><ArticleId IdType="pubmed">33488588</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K, Cortese M, Healy BC, et al.. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375:296-301.</Citation><ArticleIdList><ArticleId IdType="pubmed">35025605</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastroeni D, Nolz J, Sekar S, et al.. Laser-captured microglia in the Alzheimer's and Parkinson's brain reveal unique regional expression profiles and suggest a potential role for hepatitis B in the Alzheimer&#x2019;s brain. Neurobiol Aging. 2018;63:12-21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6686891</ArticleId><ArticleId IdType="pubmed">29207277</ArticleId></ArticleIdList></Reference><Reference><Citation>Athanasiou E, Gargalionis AN, Boufidou F, Tsakris A. The association of human herpesviruses with malignant brain tumor pathology and therapy: two sides of a coin. Int J Mol Sci. 2021;22:2250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7956256</ArticleId><ArticleId IdType="pubmed">33668202</ArticleId></ArticleIdList></Reference><Reference><Citation>Young D, Hussell T, Dougan G. Chronic bacterial infections: living with unwanted guests. Nat Immunol. 2002;3:1026-1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">12407411</ArticleId></ArticleIdList></Reference><Reference><Citation>Salama NR, Hartung ML, M&#xfc;ller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol. 2013;11:385-399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3733401</ArticleId><ArticleId IdType="pubmed">23652324</ArticleId></ArticleIdList></Reference><Reference><Citation>Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. New Engl J Med. 2008;359:2355-2365.</Citation><ArticleIdList><ArticleId IdType="pubmed">19038881</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi C, Gudino CV, Gibson Fc, 3rd, Genco CA. Review: pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol Oral Microbiol. 2010;25:305-316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2951292</ArticleId><ArticleId IdType="pubmed">20883220</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev. 2000;13:547-558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88948</ArticleId><ArticleId IdType="pubmed">11023956</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, et al..; Dubbo Infection Outcomes Study Group. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333:575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, et al.. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919-929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, et al.. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168-175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Ed&#xe9;n A, Grahn A, Bremell D, et al.. Viral antigen and inflammatory biomarkers in cerebrospinal fluid in patients with COVID-19 infection and neurologic symptoms compared with control participants without infection or neurologic symptoms. JAMA Netw Open. 2022;5:e2213253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127556</ArticleId><ArticleId IdType="pubmed">35604688</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra A, Clark JR, Kang AK, et al.. Persistent viral RNA shedding of SARS-CoV-2 is associated with delirium incidence and six-month mortality in hospitalized COVID-19 patients. GeroScience. 2022;44:1241-1254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9090540</ArticleId><ArticleId IdType="pubmed">35538386</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev. 2009;8:287-291.</Citation><ArticleIdList><ArticleId IdType="pubmed">18801465</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, Holmes TH, Anderson JN, et al.. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. PNAS. 2017;114:E7150-E7158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576836</ArticleId><ArticleId IdType="pubmed">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Raison CL, Lin JMS, Reeves WC. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain Behav Immun. 2009;23:327-337.</Citation><ArticleIdList><ArticleId IdType="pubmed">19111923</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves-Filho AJM, Macedo DS, de Lucena DF, Maes M. Shared microglial mechanisms underpinning depression and chronic fatigue syndrome and their comorbidities. Behav Brain Res. 2019;372:111975.</Citation><ArticleIdList><ArticleId IdType="pubmed">31136774</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatomi Y, Mizuno K, Ishii A, et al.. Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an &#xb9;&#xb9;C-(R)-PK11195 PET study. J Nucl Med. 2014;55:945-950.</Citation><ArticleIdList><ArticleId IdType="pubmed">24665088</ArticleId></ArticleIdList></Reference><Reference><Citation>VanElzakker MB, Brumfield SA, Lara Mejia PS. Corrigendum: neuroinflammation and cytokines in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a critical review of research methods. Front Neurol. 2019;10:316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454267</ArticleId><ArticleId IdType="pubmed">31001197</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL. Chronic fatigue syndromes: relationship to chronic viral infections. J Virol Methods. 1988;21:3-10.</Citation><ArticleIdList><ArticleId IdType="pubmed">2846619</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J Clin Virol. 2006;37:S39-S46.</Citation><ArticleIdList><ArticleId IdType="pubmed">17276367</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg J, Gottfries CG, Elfaitouri A, Rizwan M, Ros&#xe9;n A. Infection elicited autoimmunity and myalgic encephalomyelitis/chronic fatigue syndrome: an explanatory model. Front Immunol. 2018;9:229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5818468</ArticleId><ArticleId IdType="pubmed">29497420</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, Nora-Krukle Z, Henning N, et al.. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. 2018;16:268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Underhill RA. Myalgic encephalomyelitis, chronic fatigue syndrome: an infectious disease. Med Hypotheses. 2015;85:765-773.</Citation><ArticleIdList><ArticleId IdType="pubmed">26604026</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes GP, Kaplan JE, Stewart JA, Hunt B, Pinsky PF, Schonberger LB. A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-barr virus the cause? JAMA. 1987;257:2297-2302.</Citation><ArticleIdList><ArticleId IdType="pubmed">3033337</ArticleId></ArticleIdList></Reference><Reference><Citation>Ablashi DV, Eastman HB, Owen CB, et al.. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol. 2000;16:179-191.</Citation><ArticleIdList><ArticleId IdType="pubmed">10738137</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapenko S, Krumina A, Logina I, et al.. Association of active human herpesvirus-6, -7 and parvovirus B19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Adv Virol. 2012;2012:1-7. Article ID 205085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3426163</ArticleId><ArticleId IdType="pubmed">22927850</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M, Strohschein K, Giannini C, et al.. Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome. PLoS One. 2014;9:e85387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3893202</ArticleId><ArticleId IdType="pubmed">24454857</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Berk M, Galecki P, Maes M. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Mol Neurobiol. 2014;49:741-756.</Citation><ArticleIdList><ArticleId IdType="pubmed">24068616</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Blanco J, Capelli E, et al.. Myalgic encephalomyelitis/chronic fatigue syndrome - evidence for an autoimmune disease. Autoimmun Rev. 2018;17:601-609.</Citation><ArticleIdList><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelan J, Grabowska AD, Sep&#xfa;lveda N. A potential antigenic mimicry between viral and human proteins linking myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) with autoimmunity: the case of HPV immunization. Autoimmun Rev. 2020;19:102487.</Citation><ArticleIdList><ArticleId IdType="pubmed">32062027</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajdarevic R, Lande A, Rekeland I, et al.. Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci. Brain Behav Immun. 2021;98:101-109.</Citation><ArticleIdList><ArticleId IdType="pubmed">34403736</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan ZY, Barnden LR, Kwiatek RA, Bhuta S, Hermens DF, Lagopoulos J. Neuroimaging characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review. J Transl Med. 2020;18:335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7466519</ArticleId><ArticleId IdType="pubmed">32873297</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnden LR, Kwiatek R, Crouch B, Burnet R, Del Fante P. Autonomic correlations with MRI are abnormal in the brainstem vasomotor centre in Chronic Fatigue Syndrome. NeuroImage Clin. 2016;11:530-537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4833047</ArticleId><ArticleId IdType="pubmed">27114901</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson T, Zhang LX, Guo H, Nacul L, Song X. Brainstem abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: A scoping review and evaluation of magnetic resonance imaging findings. Front Neurol. 2021;12:769511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8718708</ArticleId><ArticleId IdType="pubmed">34975729</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraynak TE, Marsland AL, Wager TD, Gianaros PJ. Functional neuroanatomy of peripheral inflammatory physiology: a meta-analysis of human neuroimaging studies. Neurosci Biobehav Rev. 2018;94:76-92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6363360</ArticleId><ArticleId IdType="pubmed">30067939</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R, O&#x2019;Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46-56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2919277</ArticleId><ArticleId IdType="pubmed">18073775</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12:573-580.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley RW, Marshall WW, McDonald GG, Daugherty MA, Petty F, Fleckenstein JL. Brain abnormalities in Gulf war syndrome: evaluation with 1H MR spectroscopy. Radiology. 2000;215:807-817.</Citation><ArticleIdList><ArticleId IdType="pubmed">10831703</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraniuk JN, Shivapurkar N. Exercise &#x2013; induced changes in cerebrospinal fluid miRNAs in Gulf war Illness, chronic fatigue syndrome and sedentary control subjects. Sci Rep. 2017;7:15338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5681566</ArticleId><ArticleId IdType="pubmed">29127316</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin P, Williams MV, Klimas NG, Fletcher MA, Barnes Z, Ariza ME. Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: implications in disease pathophysiology. J Med Virol. 2017;89:1636-1645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5513753</ArticleId><ArticleId IdType="pubmed">28303641</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgopoulos AP, Tsilibary EC, Souto EP, James LM, Engdahl BE, Georgopoulso A. Adverse effects of Gulf war illness (GWI) serum on neural cultures and their prevention by healthy serum. J Neurol Neuromed. 2018;3:19-27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6486178</ArticleId><ArticleId IdType="pubmed">31032476</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilibary EC, Souto EP, James LM, Engdahl BE, Georgopoulos AP. Human immunoglobulin G (IgG) neutralizes adverse effects of Gulf war illness (GWI) serum in neural cultures: paving the way to immunotherapy for GWI. J Neurol Neuromed. 2018;3:23-28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6486180</ArticleId><ArticleId IdType="pubmed">31032477</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Rahman A, Shetty AK, Abou-Donia MB. Disruption of the blood&#x2013;brain barrier and neuronal cell death in cingulate cortex, dentate gyrus, thalamus, and hypothalamus in a rat model of Gulf-war syndrome. Neurobiol Dis. 2002;10:306-326.</Citation><ArticleIdList><ArticleId IdType="pubmed">12270692</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito P, Gheorghe D, Kandere K, et al.. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 2001;888:117-127.</Citation><ArticleIdList><ArticleId IdType="pubmed">11146058</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabis MJ, Phares TW, Kean RB, Koprowski H, Hooper DC. Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity. Proc Natl Acad Sci USA. 2008;105:15511-15516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2563072</ArticleId><ArticleId IdType="pubmed">18829442</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller DM, Pender MP, Greer JM. Blood-brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement. J Neuroimmunol. 2005;160:162-169.</Citation><ArticleIdList><ArticleId IdType="pubmed">15710469</ArticleId></ArticleIdList></Reference><Reference><Citation>Phares TW, Kean RB, Mikheeva T, Hooper DC. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol. 2006;176:7666-7675.</Citation><ArticleIdList><ArticleId IdType="pubmed">16751414</ArticleId></ArticleIdList></Reference><Reference><Citation>Welcome MO, Mastorakis NE. Stress-induced blood brain barrier disruption: molecular mechanisms and signaling pathways. Pharmacol Res. 2020;157:104769.</Citation><ArticleIdList><ArticleId IdType="pubmed">32275963</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahabi Z, Etesam F, Zandifar A, Badrfam R. Psychosocial stress, blood brain barrier and the development of anti N-methyl-D-aspartate receptor (NMDAR) encephalitis. Multiple Scler Relat Disord. 2021;50:102876.</Citation><ArticleIdList><ArticleId IdType="pubmed">33690087</ArticleId></ArticleIdList></Reference><Reference><Citation>Welcome MO. Cellular mechanisms and molecular signaling pathways in stress-induced anxiety, depression, and blood-brain barrier inflammation and leakage. Inflammopharmacology. 2020;28:643-665.</Citation><ArticleIdList><ArticleId IdType="pubmed">32333258</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Cano F, Hern&#xe1;ndez-Kelly LC, Ortega A. The blood&#x2013;brain barrier: much more than a selective access to the brain. Neurotox Res. 2021;39:2154-2174.</Citation><ArticleIdList><ArticleId IdType="pubmed">34677787</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna S, Etzioni A. MHC class I and II deficiencies. J Allergy. 2014;134:269-275.</Citation><ArticleIdList><ArticleId IdType="pubmed">25001848</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al.. Attributes and predictors of long COVID. Nat Med. 2021;27:626-631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Yomogida K, Zhu S, Rubino F, Figueroa W, Balanji N, Holman E. Post-acute sequelae of SARS-CoV-2 infection among adults aged &#x2a7e;18 years &#x2014; Long Beach, California, April 1&#x2013;December 10, 2020. MMWR Morb Mortal Wkly Rep. 2021;70:1274-1277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8445372</ArticleId><ArticleId IdType="pubmed">34529639</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavasolian F, Rashidi M, Hatam GR, et al.. HLA, immune response, and susceptibility to COVID-19. Front Immunol. 2022;11:601886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820778</ArticleId><ArticleId IdType="pubmed">33488597</ArticleId></ArticleIdList></Reference><Reference><Citation>Langton DJ, Bourke SC, Lie BA, et al.. The influence of HLA genotype on the severity of COVID-19 infection. HLA. 2021;98:14-22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251294</ArticleId><ArticleId IdType="pubmed">33896121</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen A, David JK, Maden SK, et al.. Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2. J Virol. 2020;94:e00510-e00520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7307149</ArticleId><ArticleId IdType="pubmed">32303592</ArticleId></ArticleIdList></Reference><Reference><Citation>Charonis SA, Tsilibary EP, Georgopoulos AP. In silico investigation of binding affinities between human leukocyte antigen class I molecules and SARS-CoV-2 virus spike and ORF1ab proteins. Explor Immunol. 2021;1:16-26.</Citation></Reference><Reference><Citation>Pisanti S, Deelen J, Gallina AM, et al.. Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of covid-19. J Transl Med. 2020;18:352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491019</ArticleId><ArticleId IdType="pubmed">32933522</ArticleId></ArticleIdList></Reference><Reference><Citation>James L, Tsilibary EP, Charonis S, Georgopoulos A. Commentary: COVID-19 and the path to Immunity. J Immunological Sci. 2020;4:31-33.</Citation></Reference><Reference><Citation>Charonis S, Tsilibary EP, Georgopoulos A. SARS-CoV-2 virus and Human Leukocyte Antigen (HLA) Class II: Investigation in silico of binding affinities for COVID-19 protection and vaccine development. J Immunological Sci. 2020;4:12-23.</Citation></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, et al.. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13:446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnacker S, Hartung F, Henkel F, et al.. Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages. Mucosal Immunol. 2022;15:515-524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9038526</ArticleId><ArticleId IdType="pubmed">35288643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahearn-Ford S, Lunjani N, McSharry B, et al.. Long-term disruption of cytokine signalling networks is evident in patients who required hospitalization for SARS-CoV-2 infection. Allergy. 2021;76:2910-2913. in press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222932</ArticleId><ArticleId IdType="pubmed">34028045</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt C. Publisher Correction: COVID-19 long haulers. Nat Biotechnol. 2021;39:1017-1913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8312204</ArticleId><ArticleId IdType="pubmed">34312501</ArticleId></ArticleIdList></Reference><Reference><Citation>Charonis S, James L, Georgopoulos A. In silico analysis of the binding affinities of antigenic epitopes of vaccines administered to Gulf war veterans to specific HLA Class II alleles protective for Gulf war Illness. J Neurol Neuromed. 2019;4:23-30.</Citation></Reference><Reference><Citation>Whistler T, Fletcher MA, Lonergan W, et al.. Impaired immune function in Gulf war illness. BMC Med Genomics. 2009;2:12-13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2657162</ArticleId><ArticleId IdType="pubmed">19265525</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkitny L, Middleton S, Baker K, Younger J. Evidence for abnormal cytokine expression in Gulf war Illness: A preliminary analysis of daily immune monitoring data. BMC Immunol. 2015;16:57-60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4589096</ArticleId><ArticleId IdType="pubmed">26420016</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowera A, Hotopf M, Sawicka E, et al.. Cellular immune activation in Gulf war Veterans. J Clin Immunol. 2004;24:66-73.</Citation><ArticleIdList><ArticleId IdType="pubmed">14997036</ArticleId></ArticleIdList></Reference><Reference><Citation>James LM, Engdahl BE, Leuthold AC, Georgopoulos AP. Brain correlates of human leukocyte antigen (HLA) protection in Gulf war Illness (GWI). EBioMedicine. 2016;13:72-79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5264269</ArticleId><ArticleId IdType="pubmed">27765642</ArticleId></ArticleIdList></Reference><Reference><Citation>James L, Engdahl B, Johnson R, Georgopoulos A. Gulf war illness and inflammation: Association of symptom severity with C-reactive protein. J Neurol Neuromed. 2019;4:15-19.</Citation></Reference><Reference><Citation>Johnson GJ, Slater BC, Leis LA, Rector TS, Bach RR. Blood biomarkers of chronic inflammation in Gulf war Illness. PLoS One. 2016;11:e0157855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4924830</ArticleId><ArticleId IdType="pubmed">27352030</ArticleId></ArticleIdList></Reference><Reference><Citation>James L, Johnson R, Lewis S, et al.. Lupus anticoagulant in Gulf war illness and autoimmune disorders: A common pathway toward autoimmunity. J Immunological Sci. 2021;5:14-18.</Citation></Reference><Reference><Citation>James LM, Christova P, Johnson RA, et al.. Association of lupus anticoagulant with brain atrophy in Gulf war Illness (GWI). J Immunological Sci. 2021;5:47-50.</Citation></Reference><Reference><Citation>James LM, Christova P, Engdahl BE, Lewis SM, Carpenter AF, Georgopoulos AP. Human leukocyte antigen (HLA) and Gulf war Illness (GWI): HLA-drb1*13:02 spares subcortical atrophy in Gulf war veterans. EBioMedicine. 2017;26:126-131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5832612</ArticleId><ArticleId IdType="pubmed">29137891</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgopoulos AP, James LM, Carpenter AF, Engdahl BE, Leuthold AC, Lewis SM. Gulf war illness (GWI) as a neuroimmune disease. Exp Brain Res. 2017;235:3217-3225.</Citation><ArticleIdList><ArticleId IdType="pubmed">28762055</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlin SS. A neuroimmune model of Gulf war Illness. J Environ Health Sci. 2017;3:1-11. 10.15436/2378-6841.17.1665.</Citation><ArticleIdList><ArticleId IdType="doi">10.15436/2378-6841.17.1665</ArticleId><ArticleId IdType="pmc">PMC5976257</ArticleId><ArticleId IdType="pubmed">29862319</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Callaghan JP, Michalovicz LT, Kelly KA. Supporting a neuroimmune basis of Gulf war Illness. EBioMedicine. 2016;13:5-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5264477</ArticleId><ArticleId IdType="pubmed">27806904</ArticleId></ArticleIdList></Reference><Reference><Citation>Ota M, Serada S, Naka T, Mori Y. MHC class I molecules are incorporated into human herpesvirus-6 viral particles and released into the extracellular environment. Microbiol Immunol. 2014;58:119-125.</Citation><ArticleIdList><ArticleId IdType="pubmed">24330265</ArticleId></ArticleIdList></Reference><Reference><Citation>Glosson NL, Hudson AW. Human herpesvirus-6A and -6b encode viral immunoevasins that downregulate class I MHC molecules. Virology. 2007;365:125-135.</Citation><ArticleIdList><ArticleId IdType="pubmed">17467766</ArticleId></ArticleIdList></Reference><Reference><Citation>Compeer EB, Flinsenberg TW, van der Grein SG, Boes M. Antigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation. Front Immunol. 2012;3:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3342355</ArticleId><ArticleId IdType="pubmed">22566920</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen JL, Morris CR, Solheim JC. Virus evasion of MHC class I molecule presentation. J Immunol. 2003;171:4473-4478.</Citation><ArticleIdList><ArticleId IdType="pubmed">14568919</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsakos M, McWilliam HEG, Aktepe TE, et al.. Downregulation of MHC class I expression by influenza A and B viruses. Front Immunol. 2019;10:1158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548845</ArticleId><ArticleId IdType="pubmed">31191533</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoll MP, Proen&#xe7;a JT, Efstathiou S. The molecular basis of herpes simplex virus latency. FEMS Microbiol Rev. 2012;36:684-705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3492847</ArticleId><ArticleId IdType="pubmed">22150699</ArticleId></ArticleIdList></Reference><Reference><Citation>Sausen DG, Reed KM, Bhutta MS, Gallo ES, Borenstein R. Evasion of the host immune response by Betaherpesviruses. Int J Mol Sci. 2021;22:7503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8306455</ArticleId><ArticleId IdType="pubmed">34299120</ArticleId></ArticleIdList></Reference><Reference><Citation>Colunga Biancatelli RML, Solopov PA, Sharlow ER, Lazo JS, Marik PE, Catravas JD. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in &#x39a;18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2021;321:L477-L484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384477</ArticleId><ArticleId IdType="pubmed">34156871</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirato K, Kizaki T. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon. 2021;7:e06187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7887388</ArticleId><ArticleId IdType="pubmed">33644468</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanchard M, Toomey R, Karlinsky J, Reda D, Alpern R, Xue L. Increased risk of chronic multisymptom illness in spouses of Gulf war era veterans. Mil Med. 2017;182:e1648-e1656.</Citation><ArticleIdList><ArticleId IdType="pubmed">29087907</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson PK, Shepard J, Macres M, et al.. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med. 1990;89:554-560.</Citation><ArticleIdList><ArticleId IdType="pubmed">2239975</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders DB, Wolfe GI, Benatar M, et al.. International consensus guidance for management of myasthenia gravis: Executive summary. Neurology. 2016;87:419-425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4977114</ArticleId><ArticleId IdType="pubmed">27358333</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazaridis K, Tzartos SJ. Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics. Front Immunol. 2020;11:212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7033452</ArticleId><ArticleId IdType="pubmed">32117321</ArticleId></ArticleIdList></Reference><Reference><Citation>Rock GA, Tricklebank GW, Kasaboski CA. Plasma exchange in Canada. The Canadian Apheresis Study Group. CMAJ. 1990;142:557-562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1451890</ArticleId><ArticleId IdType="pubmed">2178759</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton DM, Nair RC, Rock G. Complications of plasma exchange. Transfusion. 1989;29:124-127.</Citation><ArticleIdList><ArticleId IdType="pubmed">2919422</ArticleId></ArticleIdList></Reference><Reference><Citation>Faqihi F, Alharthy A, Abdulaziz S, et al.. Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial. Int J Antimicrob Agents. 2021;57:106334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8024223</ArticleId><ArticleId IdType="pubmed">33838224</ArticleId></ArticleIdList></Reference><Reference><Citation>Roshandel E, Sankanian G, Salimi M, et al.. Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients. Transfus Apher Sci. 2021;60:103141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8055519</ArticleId><ArticleId IdType="pubmed">33896671</ArticleId></ArticleIdList></Reference><Reference><Citation>Arulkumaran N, Thomas M, Brealey D, et al.. Plasma exchange for COVID-19 thrombo-inflammatory disease. EJHaem. 2021;2:26-32. 10.1002/jha2.140</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jha2.140</ArticleId><ArticleId IdType="pmc">PMC7754560</ArticleId><ArticleId IdType="pubmed">33363289</ArticleId></ArticleIdList></Reference><Reference><Citation>Truong AD, Auld SC, Barker NA, et al.. Therapeutic plasma exchange for COVID-19-associated hyperviscosity. Transfusion. 2021;61:1029-1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753437</ArticleId><ArticleId IdType="pubmed">33231313</ArticleId></ArticleIdList></Reference><Reference><Citation>Alharthy A, Faqihi F, Balhamar A, Memish ZA, Karakitsos D. Life-threatening COVID-19 presenting as stroke with antiphospholipid antibodies and low ADAMTS-13 activity, and the role of therapeutic plasma exchange: a case series. SAGE Open Med Case Rep. 2020;8:2050313X20964089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550946</ArticleId><ArticleId IdType="pubmed">33101686</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>